Johnson & Johnson (JNJ) EBITDA
Market Cap: $393.50B
Avg Volume: 9.04M
Industry: Drug Manufacturers - General
Sector: Healthcare
What is Johnson & Johnson's EBITDA?
- Johnson & Johnson's annual EBITDA is $24.78B.
- Johnson & Johnson's quarterly EBITDA is $5.92B.
What is EBITDA?
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.
How is EBITDA calculated?
EBITDA is calculated using the following formula:
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
Related Metrics
Other important metrics to assess Johnson & Johnson's financial health include:
- EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
- Annual: 40.39%
- Quarterly: 26.29%
- Growth EBITDA - measures the annual growth rate of the company's EBITDA:
- Annual: 6.27%
- Quarterly: 10.10%
- Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
- Annual: 44.99%
- Quarterly: 7.72%
These metrics provide insights into Johnson & Johnson's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual EBITDA
$24.78B
Quarterly EBITDA
$5.92B
Johnson & Johnson Historical EBITDA
Historical EBITDA Ratio (Annual)
Historical EBITDA Ratio (Quarterly)
Johnson & Johnson Historical EBITDA Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | EBITDA | Growth EBITDA | EBITDA Ratio | Growth EBITDA Ratio |
|---|---|---|---|---|
| 2024 | $24.78B | 6.27% | 40.39% | 44.99% |
| 2023 | $23.32B | -12.35% | 27.86% | -26.12% |
| 2022 | $26.61B | -0.55% | 37.71% | 6.57% |
| 2021 | $26.75B | 11.79% | 35.38% | 20.86% |
| 2020 | $23.93B | -2.94% | 29.27% | 8.57% |
| 2019 | $24.66B | -4.93% | 26.96% | -2.46% |
| 2018 | $25.93B | 6.94% | 27.64% | 6.53% |
| 2017 | $24.25B | -0.14% | 25.95% | -13.97% |
| 2016 | $24.28B | 3.36% | 30.16% | 11.12% |
| 2015 | $23.49B | -5.99% | 27.15% | -5.34% |
Related Metrics
Explore detailed financial metrics and analysis for JNJ.